Overall verdict
Buy
7.1/10
1-year performance
+136.82%
Score breakdown
Up 136.8% over 1 year, 60% of the 52-week range.
Strongest: Financial strength 10.0/10. Weakest: Valuation 3.5/10.
35 analysts, target +0.2% vs the price.
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits in the United States, China, Korea, Taiwan, Japan, Southeast Asia, and Europe. The company offers ALTUS systems to deposit conformal or selective films for tungsten or molybdenum metallization applications ; SABRE electrochemical deposition products for copper interconnect transition, which support copper damascene manufacturing ;
Striker single-wafer atomic layer deposition products for dielectric film solutions ; and VECTOR plasma-enhanced chemical vapor deposition (CVD) products. It also provides Akara, a conductor etch system designed to enhance etch precision, selectivity, and defect control ; Argos, Prevos, and Selis, which are selective etch systems used in the fabrication of advanced logic and memory devices that require precise control at nanoscale dimensions ;
Flex for dielectric etch applications ; Vantex, a dielectric etch system that provides RF technology and repeatable wafer-to-wafer performance enabled by Equipment Intelligence solutions ; Kiyo for conductor etch applications ; Syndion for deep silicon etch ; and Versys metal products for metal etch processes. In addition, the company offers Coronus bevel clean products to enhance die yield and Da Vinci, DV-Prime, EOS, and SP series products to address various wafer cleaning applications.
Further, it provides Reliant deposition, etch, and clean products; Sense.i platform products; and customer service, spares, and upgrades. Lam Research Corporation was incorporated in 1980 and is headquartered in Fremont, California.
Sector
Information Technology
Industry
Semiconductors and Semiconductor Equipment
Primary listing
Nasdaq
United States
CEO
Timothy Archer
Founded
1980
Employees
23 300
Revenue / employee
997 111 USD
Next earnings
October 23, 2026 (estimated)
Institutional holders
- BlackRock, Inc.10.78%
- VANGUARD CAPITAL MANAGEMENT LLC6.63%
- STATE STREET CORP4.93%
- Invesco Ltd.4.25%
- JPMORGAN CHASE & CO3.68%
- VANGUARD PORTFOLIO MANAGEMENT LLC2.97%
- GEODE CAPITAL MANAGEMENT, LLC2.80%
- FMR LLC2.73%
- PRICE T ROWE ASSOCIATES INC /MD/2.00%
- Other institutions46.29%
- Rest of the register12.94%
3119 13F filings as of June 30, 2026: US managers above $100M, filed up to 45 days after quarter end. No insiders, no retail. A share on loan is declared by its lender and by whoever bought it from the short seller, so the total can exceed 100%.
Research uses the underlying stock’s market history. The purchase quote is calculated separately when you review your order.
52-week high
438.50 USD
52-week low
125.02 USD
1-year performance
136.82%
Rising
Year-to-date performance
72.77%
Rising
Drawdown
-28.81%
Marked drawdown
Position in the 52-week range
60% of range
Against the world ETF
Over 17 years, from September 2009 to August 2026, the share did not do better than the world ETF once risk is accounted for. It earned more, but shaking 3.0 times harder: for the risk taken, the ETF paid better.
10,000 € placed at the end of September 2009 are worth today
| Lam Research | 1 307 773 € |
| World ETF | 74 620 € |
| S&P 500 | 123 025 € |
| Risk-free placement | 11 288 € |
The risk
- Shaking:the share moves 3.0 times as much as the world ETF.
- Worst fall:-50 % between January 2022 and October 2022. 10,000 € placed at the top fell to 5 039 €. The world ETF, at worst: -34 %. Back to its high in 9 months.
Lam Research earned 18 times as much as the world ETF since 2009
Value of 10,000 euros placed at the end of September 2009, dividends reinvested, in euros
- Lam Research: 1 307 773 €
- World ETF: 74 620 €
- S&P 500: 123 025 €
- Risk-free placement: 11 288 €
Based on past performance. This is not a recommendation.
Range: 105.66 USD - 132.82 USD (comparables only)
The price implies growth of 23.09% per year; the company grows at 16.46%.
Gross margin 50.5%, net margin 31.3%, ROIC 48.0%, ROE 65.1%.
Net margin
31.27%
Exceptional
Sector 10.95%|S&P 12.97%
Gross margin
50.47%
Exceptional
Return on equity (ROE)
65.07%
Exceptional
Sector 9.32%|S&P 16.52%
Return on invested capital (ROIC)
47.98%
Exceptional
Free cash flow margin (FCF)
21.05%
Exceptional
Profit-to-cash conversion (FCF conversion)
0.67x
High
Margin stability
3.2 pts
Steady
Revenue to net income
Growth
6.7/10Revenue up 30.0% over 1 year, 9.7% a year over 5, EPS 16.5% a year over 5.
Revenue (trailing 12 months)
23.2Md USD
Revenue growth (1y)
29.99%
Strong
Revenue growth (3y)
33.32%
Solid
EPS growth (1y)
34.60%
Solid
EPS CAGR (5y)
16.46%
Strong
EPS revisions (3 months)
17.99%
Sharply revised up
Valuation
3.5/10P/E 54.2x, forward P/E 33.2x, EV/EBITDA 44.3x, PEG 3.29. The multiple sits in the 92th percentile of its own 5-year history.
P/E (TTM)
54.2x
Fair
Sector 53.5x|S&P 23.0x
Forward P/E
33.2x
Expensive
EV / EBITDA
44.3x
Fair
Sector 38.1x|S&P 14.5x
PEG
3.29
Very expensive
Sector 2.09|S&P 0.86
Fair value (reverse DCF)
119.24 USD
Deeply overvalued
P/E vs its own 5-year history
among the 8% highest valuations
At its historical high
Market cap
385Md USD
Financial strength
10.0/10Cash covers 135.4% of the debt, net debt/EBITDA -0.2x.
Net debt / EBITDA
-0.2x
Very solid
Gearing (net debt / equity)
-11.69%
Net cash
Cash
5.6Md USD
Cash / market cap
1.45%
Stretched
Cash / total debt
135.37%
Net cash
Interest coverage
52.3x
Very solid
Net debt
-1.5Md USD
Equity
12.5Md USD
Closed daily candles, 2 years
Last close on September 24, 2026: 307.16 USD
- MM20296.60
- MM50304.70
- MM200270.17
- RSI 1452.9
Top panel: closed candles, 20, 50 and 200-day moving averages, with volume in grey. Bottom panel: 14-day RSI with dashed 30 and 70 levels.
200-day average slope, 1 month
+5.90%
200-day average slope, 3 months
+25.18%
50-day average slope, 1 month
-9.10%
Price structure
Lower lows
Bullish RSI divergence
No
20-day volatility
3.73 % per day
Volatility change
-15.59%
Forecasts by fiscal year
| Fiscal year | EPS | Normalised EPS | Revenue | EBITDA | Net income |
|---|---|---|---|---|---|
| 2027 | 9.40 (21) | 9.51 (30) | 34 922 (29) | 14 160 (9) | 11 767 (20) |
Amounts in millions of USD, EPS in USD per share. In brackets, the number of analysts. Consensus as of September 23, 2026.
Same sub-industry: 224 companies behind the medians.
| # | Company | Code | Country | Overall / 10 | Fundamentals / 10 | Mkt cap | P/E | Net margin | Revenue growth | ROIC | Net debt / EBITDA | FCF yield | 1-year perf. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 6857 | 8.4 | 8.4 | 141Md USD | 52.4x | 37.3 % | 39.3 % | 53.1 % | -0.6x | 1.7 % | 125.9 % | ||
| 2 | 8035 | 8.3 | 8.0 | 152Md USD | 39.8x | 23.6 % | 33.3 % | 30.1 % | -0.7x | 1.6 % | 110.8 % | ||
| 3 | AMAT | 8.0 | 7.4 | 376Md USD | 40.9x | 30.1 % | 24.8 % | 32.6 % | -0.2x | 1.5 % | 138.2 % | ||
| 4 | ASML | 7.8 | 7.7 | 659Md USD | 55.2x | 30.1 % | 21.3 % | 47.1 % | -0.7x | 1.7 % | 83.3 % | ||
| 5 | 688012 | 7.7 | 6.9 | 49.8Md USD | 75.8x | 30.0 % | 35.5 % | 16.2 % | -5.0x | 0.9 % | 85.8 % | ||
| 6 | 002371 | 7.4 | 6.2 | 71.8Md USD | 83.3x | 13.1 % | 24.0 % | 11.5 % | 0.3x | 1.3 % | 54.8 % | ||
| 7 | LRCX | 7.1 | 6.9 | 385Md USD | 54.2x | 31.3 % | 30.0 % | 48.0 % | -0.2x | 1.3 % | 136.8 % | ||
| 8 | KLAC | 7.0 | 6.3 | 245Md USD | 51.2x | 35.6 % | 15.2 % | 41.7 % | 0.2x | 1.5 % | 75.5 % | ||
| 9 | TER | 6.9 | 6.9 | 60.8Md USD | 53.4x | 25.8 % | 104.0 % | 35.9 % | -0.0x | 1.3 % | 188.2 % |
